GlassScriptPhysician profile
Brian Loring
NPI 1457980096
$2,951.19
in general payments reported to CMS, 2019-2025
9 companies · $913 in 2025
The $913 reported for 2025 was more than what 78% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $357 · 2023: $1,523 · 2024: $158 · 2025: $913.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,536 · Travel and Lodging: $1,058.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,536.19 |
| Travel and Lodging | $1,058.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,374.28 | 2022-2025 | Prostep, Infinity, N/A |
| Novus Surgical Solutions LLC | $143.99 | 2022 | |
| Averitas Pharma INC. | $119.00 | 2023-2025 | Qutenza |
| Treace Medical Concepts, INC. | $100.22 | 2024 | |
| Orthofix Medical, INC. | $85.82 | 2023-2025 | Physio-Stim |
| Acumed LLC | $49.50 | 2023 | Acumed, Osteomed |
| Novus Surgical Consultants | $36.10 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $23.75 | 2025 | |
| Bioventus LLC | $18.53 | 2025 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Loring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.